Ronald S. Lauder Honored at Connoisseur’s Dinner


Annual Gala Raised over $3.25 million for Alzheimer’s Treatments

Trish and George Vradenburg Honored at Great Ladies Luncheon, Hosted by Chris Wallace


Sixth Annual Great Ladies Luncheon & Fashion Show most successful in event's history

ADDF Again Named an Official Charity Partner of the 2016 TCS New York City Marathon


For the second year in a row, the Alzheimer’s Drug Discovery Foundation (ADDF) has been chosen as Official Charity Partner of the 2016 TCS New York City Marathon. The race will take place on Sunday, November 6, 2016.

Five New Grants Support Drug Discovery and Prevention


Grants awarded in the first two months of 2016 support researchers in the U.S. and Middle East pursuing drug programs, prevention studies, and research to accelerate clinical trials.

ADDF Joins BIRAX Regenerative Medicine Initiative


The Alzheimer's Drug Discovery Foundation (ADDF) has joined the BIRAX Initiative, which recently issues its third call for proposals. BIRAX brings together British and Israeli scientists to tackle some of the world’s most challenging diseases including cardiovascular and liver disease, diabetes and Parkinson’s. 

PsychoGenics and the ADDF Announce a Risk-Sharing Partnership for Preclinical Studies


We are partnering with PsychoGenics Inc. to bring its services to our grantees working on preclinical Alzheimer’s drug discovery programs. 

Five New Research Grants Support Clinical and Early-Stage Programs


Funded Researchers are pursuing diverse targets to treat Alzheimer's Disease.

New Members Deepen Research & Investment Expertise of ADDF Boards


At the December joint meeting, the ADDF Boards of Governors and Overseers welcomed seven new members.

Margaret and Daniel Loeb Honored at Our Sixth Annual Fall Symposium & Luncheon


On Monday, November 9, Margaret and Daniel Loeb received The Charles Evans Award from the ADDF at our Sixth Annual Fall Symposium & Luncheon. Thanks to the generosity of our donors, the Symposium & Luncheon raised more than $1 million, the most in the event’s history.

New Grant Supports Alzecure’s Work on Neurorestorative Drug


AlzeCure Foundation announced today that it has been awarded a grant from the ADDF to support the further development of its small molecule neurorestorative project.